Conestoga Discovery Fund Institutional Class CMIRX

Morningstar Medalist Rating
  • NAV / 1-Day Return $10.32  /  +0.19 %
  • Fund Size $5.6M
  • Adjusted Expense Ratio 1.250%
  • Net Expense Ratio 1.250%
  • Fee Level: Distribution High
  • Share Class Type Institutional
  • Morningstar Category Small Growth
  • Equity Style Box (Funds) Small Growth
  • Minimum Initial Investment $250,000
  • Investment Status Open
  • TTM Yield 0.00%
  • Turnover Ratio 31%

Morningstar’s Analysis CMIRX

Will CMIRX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Conestoga Discovery Institutional holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings CMIRX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 43.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Twist Bioscience Corp

5.87 332,905
Healthcare

Mama's Creations Inc Common Stock

4.89 277,695
Consumer Defensive

Palomar Holdings Inc

4.43 251,353
Financial Services

BioLife Solutions Inc

4.42 250,927
Healthcare

Digi International Inc

4.25 240,932
Technology

Transcat Inc

4.18 237,415
Industrials

CryoPort Inc

4.16 236,144
Industrials

Willdan Group Inc

3.90 221,282
Industrials

Alpha Teknova Inc

3.71 210,202
Healthcare

Construction Partners Inc Class A

3.56 202,099
Industrials

Sponsor Center